Jubilant Pharmova Ltd. (JUBILANT LIFE SCIENCES )

In News

Jubilant Pharmova arm Salisbury facility gets USFDA EIR - Medical Dialogues

Medical Dialogues - Mar 13, 2025

Jubilant Biosys Limited Seals Deal with Pierre Fabre SA - Tribune India

Tribune India - Feb 13, 2025

Jubilant Radiopharma and Simplified Imaging Solutions Announce Strategic Partnership to Support the Nuclear Medicine Community - Business Wire

Business Wire - Oct 30, 2024

Why is Jubilant Pharmova share price buzzing in an overall weak market? - Business Standard

Business Standard - Jun 13, 2025

Jubilant Pharmova shares up 3% after arm's US facility receives EIR with VAI status from USFDA; all you need to know - Upstox

Upstox - Mar 12, 2025

Jubilant HollisterStier LLC enters into cooperative agreement of $149.6 Mn with US Government to expand critical vaccine manufacturing capacity - PR Newswire

PR Newswire - May 30, 2022

Jubilant Pharmova stock gains 6.45% in an overall weak market; here's why - Mint

Mint - Nov 13, 2023

JUBLPHARMA Stock Price and Chart — NSE:JUBLPHARMA - TradingView

TradingView - Feb 12, 2021

USFDA determines inspection classification of Jubilant Pharmova's Roorkee facility - Indian Pharma Post

Indian Pharma Post - Oct 31, 2022

Jubilant Pharmova reports significant increase in Q1 net profit to Rs 481.8 crore - Medical Dialogues

Medical Dialogues - Jul 23, 2024

Stocks to Watch on March 13: Bharat Electronics, NTPC Green, Jubilant Pharmova, Satin Creditcare and more - CNBC TV18

CNBC TV18 - Mar 12, 2025

Jubilant Pharmova Hits Record After US Regulator Rules Voluntary Action For Washington Unit - NDTV Profit

NDTV Profit - Sep 11, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.